Abstract
The effects of multiple somatostatin (SRIH-14) administration on the pituitary–ovarian axis were examined in peripubertal rats. Female Wistar rats received subcutaneously, two daily doses of 20 μg SRIH-14 per 100 g body weight (b.w.) for five consecutive days (from the 33rd to the 37th day of life). Follicle-stimulating (FSH), luteinizing (LH) and somatotropic (GH) cells were examined by the peroxidase–anti-peroxidase immunocytochemical method. Changes in cell volumes, volume densities and number per unit area (mm2) of FSH-, LH- and GH-immunoreactive cells were evaluated by stereology and morphometry. Serum FSH and LH levels were determined by RIA. Ovaries were analyzed by simple point counting of follicles. The volumes and volume densities of FSH-, LH- and GH-immunoreactive cells were significantly decreased while their numbers per mm2 remained unchanged. SRIH-14 induced a significant decrease in serum FSH and LH levels. In the ovary, SRIH-14 induced an increase in the number of primordial follicles, followed by a reduction in the number of small healthy growing follicles and absence of preovulatory follicles. The number of atretic follicles was unchanged. We concluded that treatment with SRIH-14 during the peripubertal period markedly inhibited pituitary FSH, LH and GH cells. In the ovary, SRIH-14 acted by inhibiting folliculogenesis without affecting atretic processes.
Similar content being viewed by others
References
Advis JP, Ahmed CE, Ojeda SR (1989) Direct hypothalamic control of vasoactive intestinal peptide (VIP) levels in the developing rat ovary. Brain Res Bull 22:605–610
Ahmed CE, Dees WL, Ojeda SR (1986) The immature rat ovary is innervated by vasoactive intestinal peptide (VIP)-containing fibers and responds to VIP with steroid secretion. Endocrinology 118:1682–1689
Andreani CL, Lazzarin N, Pierro E, Lanzone A, Mancuso S (1995) Somatostatin action on rat ovarian steroidogenesis. Hum Reprod 10:1968–1973
Bachelot A, Monget P, Imbert-Bollore P, Coshigano K, Kopchick JJ, Kelly PA, Binart N (2002) Growth hormone is required for ovarian follicular growth. Endocrinology 143:4104–4112
Baumeister H, Kreuzer OJ, Roosterman D, Schafer J, Meyerhof W (1998) Cloning, expression, pharmacology and tissue distribution of the mouse somatostatin receptor subtype 5. J Neuroendocrinol 10:283–290
Besser GM (1976) Clinical implications of growth hormone release inhibiting hormone (GH-RIH). Curr Top Mol Endocrinol 3:115–25
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77–79
Dees WL, Ahmed CE, Ojeda SR (1986) Substance P- and vasoactive intestinal peptide-containing fibers reach the ovary by independent routes. Endocrinology 119:638–641
Gaytan F, Morales C, Bellido C, Aguilar E, Sanchez-Criado JE (1998) Ovarian follicle macrophages: is follicular atresia in the immature rat a macrophage-mediated event? Biol Reprod 58:52–59
Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717–797
Greenwald G, Roy SY (1994) Follicle development and its control. In: Knobil E, Neill J (eds) The physiology of reproduction. Raven Press, New York, pp 629–724
Hillier SG (1994) Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 9:188–191
Holst N, Jacobsen MB, Haug E, Tanbo T, Abyholm T (1995) Somatostatin in physiological concentrations inhibits basal and enhances luteinizing hormone-stimulated progesterone release from human granulosa-luteal cells. Hum Reprod 10:1363–1366
Holst N, Kierulf KH, Seppala M, Koistinen R, Jacobsen MB (1997) Regulation of insulin-like growth factor-binding protein-1 and progesterone secretion from human granulosa-luteal cells: effects of octreotide and insulin. Fertil Steril 68:478–482
Huhtaniemi I, Ahtiainen P, Pakarainen T, Rulli SB, Zhang FP, Poutanen M (2006) Genetically modified mouse models in studies of luteinising hormone action. Mol Cell Endocrinol 252:126–135
Hull KL, Harvey S (2001) Growth hormone: roles in female reproduction. J Endocrinol 168:1–23
Hull KL, Harvey S (2002) GH as a co-gonadotropin: the relevance of correlative changes in GH secretion and reproductive state. J Endocrinol 172:1–19
Kobayashi J, Mizunuma H, Kikuchi N, Liu X, Andoh K, Abe Y, Yokota H, Yamada K, Ibuki Y, Hagiwara H (2000) Morphological assessment of the effect of growth hormone on preantral follicles from 11-day-old mice in an in vitro culture system. Biochem Biophys Res Commun 268:36–41
Kumar TR, Wang Y, Lu N, Matzuk MM (1997) Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15:201–204
Lamberts SW (1988) The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 9:417–436
Lovren M, Sekulić M, Milošević V, Radulović N (1998) Effects of somatostatins on gonadotrophic cells in female rats. Acta Histochem 100:329–335
Masini MA, Sturla M, Uva B (1999) Somatostatin in the ovary of an African lungfish (Protopterus annectens): an in situ hybridisation, immunohistochemical, and autoradiographical study. Gen Comp Endocrinol 114:287–292
McGee EA, Hsueh AJ (2000) Initial and cyclic recruitment of ovarian follicles. Endocr Rev 21:200–214
McIntyre HD, Marechal DJ, Deby GP, Mathieu AG, Hezee-Hagelstein MT, Franchimont PP (1992) Immunoreactive somatostatin in the rat ovary. Acta Endocrinol (Copenh) 126:553–558
Milošević V, Nestorović N, Filipović B, Velkovski S, Starčević V (2004) Centrally applied somatostatin influences morphology of pituitary FSH cells but not FSH release. Gen Physiol Biophys 23:375–380
Mori T, Saito H, Ohno Y, Irahara M, Hosoi E, Saito S (1984) Evidence for existence of somatostatin-like immunoreactivity with molecular heterogeneity in porcine ovaries. Acta Endocrinol (Copenh) 106(2):254–259
Morley P, Armstrong DT, Calaresu FR (1990) Site at which ovarian nerve extracts inhibit thecal androgen production. Mol Cell Endocrinol 71:33–40
Nestorović N, Lovren M, Sekulić M, Filipović B, Milošević V (2001) Effects of multiple somatostatin treatment on rat gonadotrophic cells and ovaries. Histochem J 33:695–702
Nestorović N, Lovren M, Sekulić M, Negić N, Šošić-Jurjević B, Filipović B, Milošević V (2004) Chronic somatostatin treatment affects pituitary gonadotrophs, ovaries and onset of puberty in rats. Life Sci 74:1359–1373
O’Carroll AM, Krempels K (1995) Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endocrinology 136:5224–5227
Ojeda SR, Urbanski HE (1994) Puberty in the rat. In: Knobil E, Neill J (eds) The physiology of reproduction, 2nd edn. Raven Press, New York, pp 363–409
Osman P (1985) Rate and course of atresia during follicular development in the adult cyclic rat. J Reprod Fertil 73:261–270
Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157–198
Prelević GM, Wurzburger MI, Balint-Perić L, Nešić JS (1990) Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet 336:900–903
Rajkumar K, Kerr DE, Kirkwood RN, Laarveld B (1992) Inhibitory action of somatostatin-14 on hormone-stimulated cyclic adenosine monophosphate induction in porcine granulosa and luteal cells. J Endocrinol 134:297–306
Rebuffat P, Robba C, Mazzocchi G, Nussdorfer GG (1984) Inhibitory effect of somatostatin on the growth and steroidogenic capacity of rat adrenal zona glomerulosa. J Steroid Biochem 21:387–390
Reed DK, Korytko AI, Hipkin RW, Wehrenberg WB, Schonbrunn A, Cuttler L (1999) Pituitary somatostatin receptor (sst) 1–5 expression during rat development: age-dependent expression of sst2. Endocrinology 140:4739–4744
Reichlin S (1983) Somatostatin. N Engl J Med 309:1495–501; 1556–1563
Samson WK, Aguila MC, Lumpkin MD, McCann SM (1988) Somatostatin: resent studies on hypothalamic secretion and local bioaction. In: Negro-Villar A, Conn PM (eds) Peptide hormones: effects and mechanisms of action, CRC Press, Boca-Raton, pp 67–77
Schusdziarra V (1996) Somatostatin: biological actions and pathophysiology. In: Scarpignato C (ed) Octreotide: from basic science to clinical medicine. Prog Basic Clin Pharmacol, Karger, Basel, pp 35–53
Sekulić M, Lovren M, Milošević V (2000) Somatostatin acts by inhibiting pituitary TSH cells in female rats. Acta Vet 50:3–12
Shimon I, Melmed S (1997) Structure and function of somatostatin receptors in growth hormone control. J Endocrinol 155:S3–S6
Slot KA, Kastelijn J, Bachelot A, Kelly PA, Binart N, Teerds KJ (2006) Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice. Reproduction 131:525–532
Starčević V, Milošević V, Brkić B, Severs WB (2000) Effects of centrally applied somatostatin on pituitary adrenocorticotropes in female rats. Pharmacology 60:203–207
Starčević V, Milošević V, Brkić B, Severs WB (2002) Somatostatin affects morphology and secretion of pituitary luteinizing hormone (LH) cells in male rats. Life Sci 70:3019–3027
Sternberger LA, Hardy PH Jr, Cuculis JJ, Mayer HG (1970) The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 18:315–333
Strauss MC, Seelig AS, Weiss JM, Diedrich K, Ortmenn O (2003) Expression of somatostatin and its receptors in human ovary. Hum Reprod 18(Suppl 1):495
Todman MG, Han SK, Herbison AE (2005) Profiling neurotransmitter receptor expression in mouse gonadotropin-releasing hormone neurons using green fluorescent protein-promoter transgenics and microarrays. Neuroscience 132:703–712
Van Vugt HH, Swarts HJ, Van de Heijning BJ, Van der Beek EM (2004) Centrally applied somatostatin inhibits the estrogen-induced luteinizing hormone surge via hypothalamic gonadotropin-releasing hormone cell activation in female rats. Biol Reprod 71:813–819
Wandji SA, Srsen V, Voss AK, Eppig JJ, Fortune JE (1996) Initiation in vitro of growth of bovine primordial follicles. Biol Reprod 55:942–948
Wang XN, Greenwald GS (1993) Hypophysectomy of the cyclic mouse. I. Effects on folliculogenesis, oocyte growth, and follicle-stimulating hormone and human chorionic gonadotropin receptors. Biol Reprod 48:585–594
Weibel ER (1979) Practical methods for biological morphometry. Stereological methods, vol vol 1. Academic, London, pp 1–415
Wilson ME, Tanner JM (1994) Somatostatin analog treatment slows growth and the tempo of reproductive maturation in female rhesus monkeys. J Clin Endocrinol Metab 79:495–501
Yu WH, Kimura M, McCann SM (1997) Effect of somatostatin on the release of gonadotropins in male rats. Proc Soc Exp Biol Med 214:83–86
Acknowledgments
This work was supported by the Ministry for Science of Serbia, Grant number 143007B. The authors wish to express their gratitude to Dr. Svetlana Savin from the Intitute for the Application of Nuclear Energy, Belgrade, Serbia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nestorović, N., Manojlović-Stojanoski, M., Ristić, N. et al. Somatostatin-14 influences pituitary–ovarian axis in peripubertal rats. Histochem Cell Biol 130, 699–708 (2008). https://doi.org/10.1007/s00418-008-0442-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-008-0442-7